The year may be winding down, but AstraZeneca and Merck’s Lynparza sure isn’t. It picked up a blockbuster new approval late Wednesday and followed up the act by posting positive phase 3 data Thursday morning. U.S. regulators green-lighted the fast-growing PARP inhibitor in BRCA-mutated ovarian cancer patients who’ve responded partially or completely to an initial… Read More »
The winners of this year’s Nobel Prize for Medicine say they expect substantial advances toward treating cancer in the next several decades, although it is unlikely the disease could be eradicated. James Allison of the United States and Tasuku Honjo of Japan made the assessments at a Thursday news conference ahead of receiving the 9… Read More »
Queensland scientists have developed a test they hope could be “the holy grail” for diagnosing cancer. The test has been developed by University of Queensland researchers who have discovered a unique DNA nanostructure that appears to be common to all cancers. Researcher Professor Matt Trau says this has enabled an entirely new non-invasive approach to… Read More »
Ark, a Singapore-based medtech enterprise focused on early cancer detection, has raised a record US$ 40 million in Series A funding. Ark’s vision is “a world without late-stage cancer” and its mission is to eliminate late-stage cancer related death by 2048 through the introduction of accurate, affordable, and actionable cancer detection technologies. This record-breaking Series… Read More »